Xenon Pharmaceuticals Stock Forecast - 4 Period Moving Average

XENE Stock  USD 40.50  0.03  0.07%   
The 4 Period Moving Average forecasted value of Xenon Pharmaceuticals on the next trading day is expected to be 40.29 with a mean absolute deviation of 1.06 and the sum of the absolute errors of 60.47. Xenon Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Xenon Pharmaceuticals stock prices and determine the direction of Xenon Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Xenon Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
  
The current year's Inventory Turnover is expected to grow to -117.19. In addition to that, Payables Turnover is expected to decline to 10.14. The current year's Common Stock Shares Outstanding is expected to grow to about 80.8 M, whereas Net Loss is projected to grow to (106.8 M).

Open Interest Against 2025-04-17 Xenon Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Xenon Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Xenon Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Xenon Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Xenon Pharmaceuticals' open interest, investors have to compare it to Xenon Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Xenon Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Xenon. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
A four-period moving average forecast model for Xenon Pharmaceuticals is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.

Xenon Pharmaceuticals 4 Period Moving Average Price Forecast For the 1st of February

Given 90 days horizon, the 4 Period Moving Average forecasted value of Xenon Pharmaceuticals on the next trading day is expected to be 40.29 with a mean absolute deviation of 1.06, mean absolute percentage error of 1.79, and the sum of the absolute errors of 60.47.
Please note that although there have been many attempts to predict Xenon Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Xenon Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Xenon Pharmaceuticals Stock Forecast Pattern

Backtest Xenon PharmaceuticalsXenon Pharmaceuticals Price PredictionBuy or Sell Advice 

Xenon Pharmaceuticals Forecasted Value

In the context of forecasting Xenon Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Xenon Pharmaceuticals' downside and upside margins for the forecasting period are 37.98 and 42.60, respectively. We have considered Xenon Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
40.50
40.29
Expected Value
42.60
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Xenon Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Xenon Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria111.3421
BiasArithmetic mean of the errors 0.1363
MADMean absolute deviation1.0608
MAPEMean absolute percentage error0.0261
SAESum of the absolute errors60.4675
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Xenon Pharmaceuticals. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Xenon Pharmaceuticals and therefore, it cannot be a useful forecasting tool for medium or long range price predictions

Predictive Modules for Xenon Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xenon Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
38.1640.4742.78
Details
Intrinsic
Valuation
LowRealHigh
38.8941.2043.52
Details
Bollinger
Band Projection (param)
LowMiddleHigh
38.1639.6541.14
Details
16 Analysts
Consensus
LowTargetHigh
52.4857.6764.01
Details

Other Forecasting Options for Xenon Pharmaceuticals

For every potential investor in Xenon, whether a beginner or expert, Xenon Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Xenon Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Xenon. Basic forecasting techniques help filter out the noise by identifying Xenon Pharmaceuticals' price trends.

View Xenon Pharmaceuticals Related Equities

 Risk & Return  Correlation

Xenon Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Xenon Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Xenon Pharmaceuticals' current price.

Xenon Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Xenon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xenon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Xenon Pharmaceuticals stock market strength indicators, traders can identify Xenon Pharmaceuticals entry and exit signals to maximize returns.

Xenon Pharmaceuticals Risk Indicators

The analysis of Xenon Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Xenon Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xenon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Xenon Pharmaceuticals to cross-verify your projections.
For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.81)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.19)
Return On Equity
(0.27)
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.